Altered Hemorology in Adolescent Idıopathic Scoliosis
AHIAIS
Unveiling Altered Hemorheology in Adolescent Idiopathic Scoliosis: a Cross-sectional Case-control Study
2 other identifiers
observational
60
1 country
1
Brief Summary
This study aims to investigate potential alterations in hemorheological parameters in adolescents with idiopathic scoliosis (AIS) compared to healthy controls. A total of 30 AIS patients and 30 age- and sex-matched healthy individuals will be evaluated through clinical, radiological, and laboratory assessments. Hematocrit, plasma and whole blood viscosity, erythrocyte deformability, and aggregation will be measured. The goal is to determine whether structural spinal deformities in AIS are associated with changes in microcirculatory blood flow properties.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2025
CompletedFirst Submitted
Initial submission to the registry
July 9, 2025
CompletedFirst Posted
Study publicly available on registry
August 5, 2025
CompletedAugust 5, 2025
July 1, 2025
10 months
July 9, 2025
July 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Plasma viscosity (PV)
Measurement of plasma viscosity (mPa·s) using cone-plate viscometry at a shear rate of 450 s-¹.
At baseline (single time point)
Whole blood viscosity (WBV)
Measurement of whole blood viscosity (mPa·s) using cone-plate viscometer at multiple shear rates (37.5 to 450 s-¹).
At baseline (single time point)
Erythrocyte deformability (EImax)
Evaluation of erythrocyte elongation index (EImax) using laser-assisted ektacytometry (Lorrca MaxSis).
At baseline (single time point)
Erythrocyte deformability (SS1/2)
Evaluation of shear stress at half EImax (SS1/2) using laser-assisted ektacytometry (Lorrca MaxSis).
At baseline (single time point)
Erythrocyte aggregation (AI and Tr)
Measurement of aggregation index (AI) using Lorrca MaxSis at 37°C under standardized conditions.
At baseline (single time point)
Erythrocyte aggregation (Tr)
Measurement of relaxation time (Tr) using Lorrca MaxSis at 37°C under standardized conditions.
At baseline (single time point)
Secondary Outcomes (42)
Correlation between Cobb angle and the Plasma viscosity (mPa·s)
At baseline (single time point)
Correlation between cervical lordosis angle and the Plasma viscosity (mPa·s)
At baseline (single time point)
Correlation between thoracic kyphosis angle and the Plasma viscosity (mPa·s)
At baseline (single time point)
Correlation between lumbar lordosis angle and the Plasma viscosity (mPa·s)
At baseline (single time point)
Correlation between angle of trunk rotation (ATR) and the Plasma viscosity (mPa·s)
At baseline (single time point)
- +37 more secondary outcomes
Study Arms (2)
Patients
10-18 years old AIS patients
Control Healthy Subjects
Sex and aged match healthy subjecyts
Eligibility Criteria
This case-control study occurred at the University of Health Sciences in Istanbul from January to May 2025. Participation was voluntary, and written informed consent was obtained from both the adolescents and their legal guardians prior to data collection. Adolescents with idiopathic scoliosis will initially be recruited. An equal number of age-matched and sex-matched healthy controls will also be included. All participants will undergo the same evaluation protocol, and inclusion/exclusion criteria will be applied consistently across both groups.
You may qualify if:
- Presence of structural scoliosis with a Cobb angle greater than 10°
- Age between 10 and 18 years
You may not qualify if:
- Other types of scoliosis, such as syndromic conditions, congenital vertebral deformities, and neuromuscular scoliosis
- Presence of any diseases or conditions that may affect hemorheology, such as cardiovascular, respiratory, and hematologic diseases
- Obesity (Body mass index \[BMI\] \> 30)
- Being treated surgically for scoliosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences
Istanbul, Turkey (Türkiye)
Related Links
- Lazari D, Freitas Leal JK, Brock R, Bosman G. The Relationship Between Aggregation and Deformability of Red Blood Cells in Health and Disease. Front Physiol 2020;11:288.
- Ebenuwa I, Violet P-C, Tu H, Lee C, Munyan N, Wang Y, et al. Altered RBC deformability in diabetes: clinical characteristics and RBC pathophysiology. Cardiovasc Diabetol 2024;23:370.
Biospecimen
blood
Study Officials
- STUDY DIRECTOR
Papatya Keles, professor
Saglik Bilimleri Universitesi
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 9, 2025
First Posted
August 5, 2025
Study Start
April 4, 2024
Primary Completion
January 20, 2025
Study Completion
June 7, 2025
Last Updated
August 5, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to privacy concerns and institutional policies. The data contains sensitive health information that cannot be sufficiently de-identified for public distribution.